Who owns Denali Therapeutics Inc (DNLI)? Superinvestor holders

4 superinvestors of the 157 tracked here hold Denali Therapeutics Inc (DNLI) in their latest 13F filing, with $571.3M between them. Julian and Felix Baker gives it the most weight: 0.48% of the reported portfolio. In their latest reported quarter, Julian and Felix Baker and Brandon Haley added; Baillie Gifford team reduced.

Hold it now
4
of 157 tracked
Combined value
$571.3M
Bought / sold
2 / 1
last quarter

Key facts

Superinvestors holding it
4 of 157
Biggest holder
Baillie Gifford team, $229.8M
Largest weight
Julian and Felix Baker, 0.48%of their portfolio
Combined value
$571.3M
Bought last quarter
2
Sold last quarter
1

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding DNLI, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Julian and Felix BakerBaker Bros. Advisors0.48%$96M3.73M▲ Added 0.07%+2.61KQ2 2026
2TemasekTemasek Holdings0.40%$145M7.01MNo change0Q3 2026
3Brandon HaleyHolocene Advisors0.23%$100.4M3.91M▲ Added 22%+709.72KQ2 2026
4Baillie Gifford teamBaillie Gifford & Co0.22%$229.8M11.12M▼ Reduced 7.0%−840.84KQ3 2026

Quarter by quarter

Superinvestor ownership of DNLI by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 202692218.13M$374.8M01
Q2 2026157426.61M$684.5M22
Q1 2026157422.88M$439.2M11
Q4 2025157323.06M$380.6M20
Q3 2025157320.68M$300.3M01
Q2 2025157321.04M$294.4M01
Q1 2025156321.18M$287.9M01
Q4 2024156321.4M$436.2M02

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of DNLI held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Baillie Gifford team11.12M11.96M12.07M12.31M11.59M11.96M12.09M12.31M
Temasek7.01M7.01M7.01M7.01M5.36M5.36M5.36M5.36M
Brandon Haley·3.91M——————
Julian and Felix Baker·3.73M3.73M3.73M3.73M3.73M3.73M3.73M
Polen Capital team——65.3K—————

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own DNLI?

In their latest 13F filings: Julian and Felix Baker (0.48% of the portfolio, $96M), Temasek (0.40% of the portfolio, $145M), Brandon Haley (0.23% of the portfolio, $100.4M), Baillie Gifford team (0.22% of the portfolio, $229.8M).

Who bought DNLI last quarter?

Julian and Felix Baker (added 0.1%), Brandon Haley (added 22%). “Last quarter” is each investor's latest reported quarter.

Who sold DNLI last quarter?

Reduced: Baillie Gifford team (7.0% fewer shares).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Denali Therapeutics Inc (DNLI)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/DNLI/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to DNLI by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.